NE
Neuphoria Therapeutics Inc. (NEUP)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$3.98
+2.45%
Mkt Cap $8.54M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$7.00
Range $7.00 – $7.00
Implied Upside
+76.1%
Consensus $7.00 vs current $3.98